Get up-to-the-minute news sent straight to your device.

They randomized 368 people (abemaciclib+fulvestrant, n=182; placebo+fulvestrant, n=186) who had disease progression after prior CDK4/6 inhibitors plus aromatase inhibitors or after adjuvant therapy.

After hours: December 24 at 4:20:00 PM EST Loading Chart for MCRI ...

The day after Christmas on a foggy Thursday morning at Colonial Village shopping plaza, Katschke and his store, Monarch Comics, returned to business for the first "new comic book day" in three weeks.

Hope S. Rugo, MD, FASCO, discusses the role of abemaciclib plus elacestrant for ER+/HER2– MBC from data presented at SABCS 2024. NEWS All News FDA Briefs Oncology Icons Special Reports The Targeted ...

Bonus Sep 13, 2024 Sep 13, 2024 Jul 28, 2024 Bonus Ratio: 1 share(s) for every 1 shares held Rights Sep 11, 1995-Sep 01, 1995 Rights ratio: 1 share for every 2 held at a price of Rs 10.0 Rights--Jul ...

Last year, MSD and Moderna started the INTerpath-002 study of the combination as adjuvant therapy for patients with stage 2 to 3b NSCLC that has been removed with surgery, without neoadjuvant ...

Additionally, there is the adjuvant QS-21, used in several innovative vaccines against diseases, plus promising new vaccine and immunotherapy treatments in the oncology space. BSI is now using its ...

The following is a summary of “Neoadjuvant Pembrolizumab in Stage I-III Deficient Mismatch Repair Colon Cancer: A Clinical Trial,” published in the December 2024 issue of Surgery by Gögenur et al.

Nat Clin Pract Oncol. 2008;5(9):531-542. The authors declared no competing interests. Cite this: The Role of Hormonal Therapy in the Management of Hormonal-Receptor-Positive Breast Cancer With Co ...